CIK 0001583771
- Non-accelerated filer
- Smaller reporting company
Hepion Pharmaceuticals, Inc.
Sign in to watch- Tickers
- HEPA CTRVP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462783806
- Phone
- +1 732-902-4000
- Business address
- 34 SHREWSBURY AVE., SUITE 1D, RED BANK, NJ, 07701
- Former names
- ContraVir Pharmaceuticals, Inc.
Securities
- HEPA Common stock OTC
- CTRVP Common stock OTC
- Open-market buys, last 90 days
- $10,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$10,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-03 | SAPIRSTEIN JAMES Chief Executive Officer | Grant or award | +322,092 | 492,819 | ||
| 2017-07-06 | SAPIRSTEIN JAMES Chief Executive Officer | Grant or award | +141,061 | 170,727 | ||
| 2017-03-06 | SAPIRSTEIN JAMES Chief Executive Officer | Grant or award · Stock Options | +313,898 | 2,761,129 | ||
| 2017-03-03 | SAPIRSTEIN JAMES Chief Executive Officer | Grant or award · Stock Options | +313,898 | 2,447,231 | ||
| 2016-10-27 | SAPIRSTEIN JAMES Chief Executive Officer | Exercise or conversion | +16,666 | $1.50 | $25K | 29,666 |
| 2016-10-27 | SAPIRSTEIN JAMES Chief Executive Officer | Exercise or conversion · Stock Options | −16,666 | 2,133,334 | ||
| 2016-06-13 | SAPIRSTEIN JAMES Chief Executive Officer | Grant or award · Stock Options | +500,000 | 2,150,000 | ||
| 2016-02-18 | SAPIRSTEIN JAMES Chief Executive Officer | Purchase | +10,000 | $1.00 | $10K | 13,000 |
| 2015-11-30 | SAPIRSTEIN JAMES Chief Executive Officer | Purchase | +500 | $2.15 | $1K | 3,000 |
| 2015-11-23 | SAPIRSTEIN JAMES Chief Executive Officer | Purchase | +2,500 | $1.64 | $4K | 2,500 |
| 2015-06-04 | SAPIRSTEIN JAMES Chief Executive Officer | Grant or award · Stock Options | +150,000 | 1,650,000 | ||
| 2014-12-03 | SAPIRSTEIN JAMES Chief Executive Officer | Grant or award · Stock Options | +500,000 | 1,500,000 |
Page 1 of 1 · 12 trades